Vistra Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Vistra Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.74B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $17.22B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $14.78B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $13.73B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $12.08B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $11.44B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $2.86B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $3.19B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $2.83B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $2.92B | Feb 28, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.59B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.76B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $13.80B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $15.63B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $17.70B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $10.85B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $11.55B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $9.80B | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $944.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.66B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.49B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($1.23B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($1.27B) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $636.00M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $234.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $113.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $356.00M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $225.00M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.91B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.08B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.66B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($1.18B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($1.52B) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.52B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $334.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $440.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $729.00M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $490.00M | Feb 28, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.60B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.31B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.19B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.04B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $904.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $926.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $600.00M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.56B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $5.45B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $485.00M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($206.00M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $3.34B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.74B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.47B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.39B | Feb 28, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.08B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.68B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.30B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.03B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.26B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $713.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $530.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $114.00M | Feb 28, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $37.77B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $32.97B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $32.79B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $29.68B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $25.21B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $26.62B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $26.02B | Feb 28, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.44B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $32.19B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $27.64B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $27.87B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $21.39B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $16.85B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $18.66B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $18.16B | Feb 28, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.57B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $5.31B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.90B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.29B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $8.37B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $7.96B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $7.86B | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.81B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.81B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.58B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.58B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.58B | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | $2.58B | Mar 1, 2023 |
| FY2022 | Dec 31, 2019 | $2.55B | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $2.07B | Feb 25, 2022 |
| FY2019 | Dec 31, 2017 | $1.91B | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.00M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($454.00M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($2.61B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($3.64B) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($1.96B) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($399.00M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($764.00M) | Feb 26, 2021 |
| FY2019 | Jan 1, 2019 | ($1.45B) | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | ($1.45B) | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $785.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.19B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.49B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $455.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.33B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $406.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $300.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $636.00M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.04B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $16.30B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $14.40B | Feb 28, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 338.06M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 339.75M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 351.46M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 389.75M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 469.07M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 489.31M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 487.70M | Feb 26, 2021 |
| FY2020 | Dec 31, 2018 | 493.22M | Feb 26, 2021 |
| FY2020 | Apr 9, 2018 | 522.93M | Feb 26, 2021 |
| FY2020 | Dec 31, 2017 | 428.40M | Feb 26, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $306.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $305.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $313.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $302.00M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $290.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $266.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $243.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $0 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $0 | Feb 28, 2020 |